Genetic variability of the core protein in hepatitis C virus genotype 4 in Saudi Arabian patients and its implication on pegylated interferon and ribavirin therapy

被引:0
作者
Fatimah S Alhamlan
Mohammed N Al-Ahdal
Nisreen Z Khalaf
Ayman A Abdo
Faisal M Sanai
Hamad I Al-Ashgar
Mahmoud ElHefnawi
Amina Zaid
Ahmed A Al-Qahtani
机构
[1] King Faisal Specialist Hospital and Research Center MBC 03,Department of Infection and Immunity
[2] King Faisal Specialist Hospital and Research Center,Department of Pathology and Laboratory Medicine
[3] College of Medicine,Department of Microbiology and Immunology
[4] Alfaisal University,Liver Disease Research Center
[5] King Saud University,Department of Medicine
[6] Section of Gastroenterology,Hepatobiliary Sciences and Liver Transplantation
[7] College of Medicine,Department of Medicine
[8] King Saud University,Biomedical Informatics and Chemo Informatics group, Informatics and Systems Dept.
[9] King Abdulaziz Medical City,Molecular Diagnostics and Therapeutics Department
[10] King Faisal Specialist Hospital & Research Center,undefined
[11] National Research Centre,undefined
[12] Scientific Institute and Research Academy (SIRA-Corp),undefined
[13] Genetic Engineering and Biotechnology Research Institute,undefined
[14] Sadat City University,undefined
来源
Journal of Translational Medicine | / 12卷
关键词
Hepatitis C Virus (HCV) Treatment; Genotype 4; PEG-IFN/RBV combined therapy;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 183 条
[1]  
Chevaliez S(2006)Hepatitis C virus serologic and virological tests and clinical diagnosis of HCV-related liver disease Int J Med Sci 3 35-40
[2]  
Pawlotsky JM(2007)Use of sequence analysis of the NS5b region for routine genotyping of hepatitis C virus with reference to C/E1 and 50 untranslated region sequences J Clin Micro 45 1102-1112
[3]  
Murphy DG(2005)Consensus proposals for a unified system of nomenclature of hepatitis C virus genotypes Hepatology 42 962-973
[4]  
Willems B(2004)Diagnosis, management, and treatment of hepatitis C Hepatology 39 1147-1171
[5]  
Deschenes M(2007)Predictive factors of early and sustained responses to peginterferon plus ribavirin combination therapy in Japanese patients infected with hepatitis C virus genotype 1b: amino acid substitutions in the core region and low-density lipoprotein cholesterol levels J Hepatol 46 403-410
[6]  
Hilzenrat N(2009)A matched case-controlled study of 48 and 72 weeks of peginterferon plus ribavirin combination therapy in patients infected with HCV genotype 1b in Japan: amino acid substitutions in HCV core region as predictor of sustained virological response J Med Virol 81 452-458
[7]  
Mousseau R(2011)Management of hepatitis C virus genotype 4: recommendations of an international expert panel J Hepatol 54 1250-1262
[8]  
Sabbah S(2013)IL28B polymorphisms predict the virological response to standard therapy in patients with chronic hepatitis C virus genotype 4 infection Hepatol Int 7 533-538
[9]  
Simmonds P(2003)Determining hepatitis C genotype by analyzing the sequence of the NS5b region J Virol Methods 109 187-193
[10]  
Bukh J(2000)DNASTAR's Lasergene sequence analysis software Methods Mol Biol 132 71-91